| Literature DB >> 28720228 |
Jane T Garvin1, Lovoria B Williams2, Thomas V Joshua2, Stephen W Looney3, Lucy N Marion2.
Abstract
OBJECTIVE: To calculate the percent weight reduction required to achieve minimal clinically important improvement (MCII) in health-related quality of life (HRQOL).Entities:
Keywords: African American; Body composition; Body mass index; EQ-5D; Health-related quality of life; Minimal clinically important difference; Obesity; Quality of life; SF-12; Waist circumference; Waist-to-height ratio
Mesh:
Year: 2017 PMID: 28720228 PMCID: PMC5549628 DOI: 10.1016/j.apnr.2017.06.002
Source DB: PubMed Journal: Appl Nurs Res ISSN: 0897-1897 Impact factor: 2.257
Baseline background characteristics (N = 472 Participants)
| Measure | Mean (SD) | # (%) |
|---|---|---|
| Age | 47.1 (10.5) | |
| Female | 392 (83) | |
| College Graduate | 244 (52) | |
| Employed | 379 (80) | |
| Married | 254 (54) | |
| Cigarette Use | 92 (20) | |
| Alcohol Use | 182 (39) | |
| Diabetic Parent | 188 (40) | |
| FPG | 90 (9) | |
| A1C | 5.8 (0.5) | |
| Weight (kg) | 98.5 (21.2) | |
| BMI | 35.6 (7.4) | |
| WC (cm) | 107.5 (15.4) | |
| W-Ht Ratio | 0.65 (0.09) | |
| Obesity Classification by BMI Categories | ||
| Overweight (BMI 25 – 29.99) | 129 (27) | |
| Class I Obesity (BMI 30 – 34.99) | 129 (27) | |
| Class II Obesity (BMI 35 – 39.99) | 105 (22) | |
| Class III Obesity (BMI 40 or more) | 109 (23) | |
Note
BMI: Body mass index
FPG: Fasting plasma glucose
WC: Waist circumference
W-Ht: Waist-to - height
HRQOL at baseline and 1 year follow-up (N =472)
| Measure | Baseline Mean (SD) | 1 Year Follow-up Mean (SD) |
|---|---|---|
| PCS | 48.8 (8.5) | 49.6 (8.7) |
| MCS | 52.4 (8.8) | 52.4 (8.6) |
| HS | 79.4 (14.8) | 82.9 (13.5) |
Note
EQ-5D HS: Health status on the EuroQol-5 D
HRQOL: Health-related quality of life
SF-12 MCS: Mental component summary of the Short Form-12 Health Survey
SF-12 PCS: Physical component summary of the Short Form-12 Health Survey
Final regression models for improvement in SF-12 Physical Component Summary
| Variable | ||||
|---|---|---|---|---|
| Baseline BMI | 0.122 | 2.247 | .025 | (0.015, 0.228) |
| Percent weight reduction, baseline to one year | 0.278 | 3.988 | .001 | (0.141, 0.416) |
| Percent weight reduction, baseline to one year | 0.247 | 2.109 | .036 | (0.016, 0.477) |
| Baseline BMI | 0.215 | 2.583 | .011 | (0.051, 0.379) |
| Percent weight reduction, baseline to one year | 0.393 | 3.589 | <.001 | (0.177, 0.610) |
| Female | −7.663 | −2.164 | .033 | (−14.681, −0.645) |
| Percent weight reduction, baseline to one year | 0.429 | 2.780 | .006 | (0.123, 0.735) |
| A1C | 7.056 | 2.561 | .013 | (1.560, 12.552) |
| Percent weight reduction, baseline to one year | 0.442 | 2.226 | .029 | (0.046, 0.838) |
| Percent weight reduction, baseline to one year | 0.477 | 2.522 | .015 | (0.097, 0.857) |
Note
A1C: Hemoglobin A1C, glycosylated hemoglobin
BMI: Body mass index
EQ-5D HS: Health status on the EuroQol-5D
SF-12 PCS: Physical component summary on the SF-12
p < .05
Final regression model for improvement in EQ-5D Health Status
| Variable | ||||
|---|---|---|---|---|
| Age | −0.122 | −2.231 | .026 | (−0.283, −0.018) |
| Percent weight reduction, baseline to one year | 0.337 | 2.727 | .007 | (0.094, 0.580) |
| Age | −0.271 | −2.357 | .019 | (−0.497, −0.044) |
| Percent weight reduction, baseline to one year | 0.388 | 2.018 | .045 | (0.009, 0.768) |
| Baseline A1C | −6.252 | −2.226 | .027 | (−11.796, −0.708) |
| Percent weight reduction, baseline to one year | 0.591 | 2.177 | .032 | (0.053, 1.129) |
| Percent weight reduction, baseline to one year | 0.708 | 2.113 | .038 | (0.040, 1.376) |
Note
A1C: Hemoglobin A1C, glycosylated hemoglobin
BMI: Body mass index
EQ-5D HS: Health status on the EuroQol-5D
SF-12 PCS: Physical component summary on the Short Form-12 Health Survey No significant model for participants with baseline BMI ≥ 40 and baseline EQ-5D HS < 80.
p < .05
Percent weight reduction required for minimal clinically important improvement in HRQOL
| HRQOL | N | Adjusted | ||
|---|---|---|---|---|
| SF-12 PCS | 472 | 18 | 18 | 18 |
| EQ-5D Health Status | 472 | 33 | 30 | 30 |
| SF-12 PCS | 205 | 20 | 20 | 21 |
| EQ-5D Health Status | 205 | 25 | 26 | 25 |
| SF-12 PCS | 172 | 12 | 13 | 13 |
| EQ-5D Health Status | 172 | NC | NC | NC |
| SF-12 PCS | 111 | 12 | 12 | 12 |
| EQ-5D Health Status | 111 | 17 | 17 | 15 |
| SF-12 PCS | 72 | 12 | 11 | 11 |
| EQ-5D Health Status | 72 | 14 | 14 | 14 |
| SF-12 PCS | 52 | 10 | 10 | 11 |
| EQ-5D Health Status | 52 | NC | NC | NC |
Note
Adjustments based on the final models presented in Tables 3 and 4
Adjusted for age, gender, and baseline body mass index A1C: Hemoglobin A1C, glycosylated hemoglobin
BMI: Body mass index
EQ-5D HS: Health status on the EuroQol-5D
HRQOL: Health-related Quality of Life
NC: Not calculated as percent weight reduction was not a significant variable
SF-12 PCS: Physical component summary on the Short Form-12 Health Survey